Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients

Breast Cancer Research and Treatment

Volumn 147, Issue 2, 2014, Pages 371-380

  Rubio, Isabel T ^a   Espinosa Bravo, Martin ^a   Rodrigo, Maxi ^b   Diaz, Maria Amparo Viguri ^c   Hardisson, David ^d   Sagasta, Amaia ^e   Dueñas, Basilio ^c   Peg, Vicente ^a,f  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

^c HUA Txagorritxu ^*  (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Prediction; Sentinel lymph node; Total tumoral load

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MEASUREMENT ACCURACY; NOMOGRAM; NONSENTINEL LYMPH NODE METASTASIS; NUCLEIC ACID AMPLIFICATION; ONCOLOGICAL PARAMETERS; ONE STEP NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE; TOTAL TUMORAL LOAD; TUMOR VOLUME; VERY ELDERLY;

EID: 85027944220     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3108-2     Document Type: Article

References (41)

1. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Constantino JP et al (2010) Sentinel lymph node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933
2. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7(12):983–990
3. Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98:599–600
4. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ et al (2001) Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 182:316–320
5. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Berstein F, Kuerer HM et al (2007) Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723–730
6. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM et al (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastasis: the American College of Surgeons Oncology group z0011 randomized trial. Ann Surg 252:426–432
7. Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK et al (2003) A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10:1140–1151
8. Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113–119
9. Saidi RF, Dudrick PS, Remine SG, Mittal VK (2004) Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 70:101–105
10. Degnim AC, Reynolds C, Pantvaidya G, Zakaria S, Hoskin T, Barnes S et al (2005) Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 190:543–550
11. Kohrt HE, Olshen RA, Bermas HR, Goodson WH, Wood DJ, Henry S et al (2008) New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer 8:66
12. Pal A, Provenzano E, Duffy SW, Pinder SE, Purushotham AD (2008) A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive. Br J Surg 95:302–309
13. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R et al (2012) Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255:109–115
14. Bolster MJ, Peer PG, Bult P, Thunnissen FB, Schapers RF, Meijer JW et al (2007) Risk factors for non sentinel lymph node metastases in patients with breast cancer. The outcome of a multi-institutional study. Ann Surg Oncol 14:181–189
15. Ozmen V, Karanlik H, Cabioglu N, Igci A, Kecer M, Asoglu O et al (2006) Factors predicting the sentinel and non sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 95:1–6
16. Patani N, Mokbel K (2009) The clinical significance of sentinel lymph node micrometastasis in breast cancer. Breast Cancer Res Treat 114:393–402
17. Castellano I, Macri L, Deambrogio C, Balmativola D, Bussone R, Ala A et al (2011) Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases. Ann Surg 00:1–9
18. Cserni G (2012) Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification. J Clin Pathol 65(3):193–199
19. Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F et al (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13:4807–4816
20. Visser M, Jiwa M, Horstman A, Brink AA, Pol RP, van Diest P et al (2008) Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 122:2562–2567
21. Tamaki Y, Akiyama F, Iwase T, Kaneko T, Tsuda H, Sato K, Ueda S et al (2009) Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 15:2879–2884
22. Espinosa-Bravo M, Sansano I, Pérez-Hoyos S, Ramos M, Sancho M, Xercavins J et al (2013) Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay. Eur J Surg Oncol 39(7):766–773
23. Peg V, Espinosa-Bravo M, Vieites B, Vilardell F, Antúnez JR, de Salas MS et al (2013) Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients. Breast Cancer Res Treat 139(1):87–93
24. Rubio IT, Aznar F, Lirola J, Peg V, Xervacins J et al (2010) Intraoperative assessment of sentinel lymph nodes after neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol 17(1):235–239
25. Edge SBBD, Compton CC, Fritz AG et al (2010) AJCC cancer staging manual, 7th edn. Springer, New York
26. Steyerberg EW, Borsboom GJ, van Houwelingen HC, Eijkemans MJ, Habbema JD (2004) Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med 23:2567–2586
27. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR et al (2011) A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 117(12):2599–2607
28. Osako T, Iwase T, Kimura K, Horii R, Akiyama F (2013) Sentinel tumor burden quantified based on cytokeratin 19 mRNA copy number predicts non sentinel node metastases in breast cáncer: molecular whole-node analysis of all removed nodes. Eur J Cancer 49(6):1187–1196
29. Meretoja TJ, Leidenius MH, Heikkila PS, Boross G, Sejben I, Regitnig P et al (2012) International multicenter tool to predict the risk of nonsentinel node metastasis in breast cancer. J Natl Cancer Inst 104(24):1888–1896
30. Crabb SJ, Cheand MC, Leung S, Immonen T, Nielsen TO, Huntsman DD et al (2008) Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metàstasis in primary breast cancer. Clin Breast Cancer 8:249–256
31. Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S et al (2009) Axillary lymph node status of operable breast càncers by combined steroid receptor and Her2 status: triple positive tumors are more likely lymph node positive. Breast Cancer Res Treat 113:181–187
32. Jones T, Neboori H, Wu H, Yang Q, Haffty BG, Evans S et al (2013) Are breast cancer subtypes prognostic for nodal involvement and associated with clinicopathologic features at presentation in early stage breast càncer? Ann Surg Oncol 20(9):2866–2872
33. Coutant C, Olivier C, Lambaudie E, Fondrinier E, Marchai F, Guillemin F et al (2009) Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multicenter study. JCO 27:2800–2808
34. Klar M, Jochmann A, Foeldi M, Stumpf M, Gitsch G, Stickeler E, Watermann D (2008) The MSKCC nomogram for prediction the likelihood of non sentinel node involvement in a German breast cancer population. Breast Cancer Res Treat 112:523–531
35. Andersson Y, Frisell J, de Boniface J, Bergkvist L (2012) Prediction of non sentinel node status in breast cancer patients with sentinel lymph node metastases: evaluation of the Tenon Score. Breast Cancer Clin Res 6:31–38
36. Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ (2005) Predicting nonsentinel node status after positive lymph biopsy for breast cancer: clinicians versus nomogram. Ann Surg Oncol 12(8):654–658
37. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A et al (2012) American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol 19(10):3144–3151
38. Latosinsky S, Berrang TS, Cutter CS, George R, Olivotto I, Julian TB (2012) Axillary dissection versus non axillary dissection in women with invasive breast cancer and sentinel node metástasis. Can J Surg 55:66–69
39. Massimino KP, Hessman CJ, Ellis MC, Naik AM, Vetto JT (2012) Impact of American College of Surgeons Oncology Group Z0011 and National Surgical Adjuvant Breast and Bowel Project B-32 trial results on surgeon practice in the Pacific Northwest. Am J Surg 203(5):618–622
40. Loveland-Jones CE, Ruth K, Sigurdson ER, Egleston BL, Boraas M, Bleicher RJ (2014) Patterns of nodal staging during breast conservation surgery in the medicare patient: will the ACOSOG Z0011 trial change the pattern of care? Breast Cancer Res Treat 143(3):571–577
41. Caudle A, Hunt KK, Kuerer HM, Meric-Berstein F, Lucci A, Bedrosian I, Babiera GV et al (2011) Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol 18(9):2407–2412